Humanwell Healthcare Group Co Ltd (600079) - Net Assets

Latest as of June 2025: CN¥21.41 Billion CNY ≈ $3.13 Billion USD

Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has net assets worth CN¥21.41 Billion CNY (≈ $3.13 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥37.56 Billion ≈ $5.50 Billion USD) and total liabilities (CN¥16.15 Billion ≈ $2.36 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Humanwell Healthcare Group Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥21.41 Billion
% of Total Assets	57.0%
Annual Growth Rate	18.89%
5-Year Change	59.95%
10-Year Change	125.37%
Growth Volatility	22.69

Humanwell Healthcare Group Co Ltd - Net Assets Trend (2000–2024)

This chart illustrates how Humanwell Healthcare Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Humanwell Healthcare Group Co Ltd asset portfolio for the complete picture of this company's asset base.

Annual Net Assets for Humanwell Healthcare Group Co Ltd (2000–2024)

The table below shows the annual net assets of Humanwell Healthcare Group Co Ltd from 2000 to 2024. For live valuation and market cap data, see Humanwell Healthcare Group Co Ltd market capitalisation.

Year	Net Assets	Change
2024-12-31	CN¥20.69 Billion ≈ $3.03 Billion	+2.96%
2023-12-31	CN¥20.10 Billion ≈ $2.94 Billion	+12.02%
2022-12-31	CN¥17.94 Billion ≈ $2.63 Billion	+14.65%
2021-12-31	CN¥15.65 Billion ≈ $2.29 Billion	+20.97%
2020-12-31	CN¥12.94 Billion ≈ $1.89 Billion	-7.57%
2019-12-31	CN¥14.00 Billion ≈ $2.05 Billion	-1.93%
2018-12-31	CN¥14.27 Billion ≈ $2.09 Billion	-14.06%
2017-12-31	CN¥16.61 Billion ≈ $2.43 Billion	+38.59%
2016-12-31	CN¥11.98 Billion ≈ $1.75 Billion	+30.50%
2015-12-31	CN¥9.18 Billion ≈ $1.34 Billion	+60.31%
2014-12-31	CN¥5.73 Billion ≈ $838.16 Million	+12.74%
2013-12-31	CN¥5.08 Billion ≈ $743.41 Million	+39.20%
2012-12-31	CN¥3.65 Billion ≈ $534.05 Million	+16.27%
2011-12-31	CN¥3.14 Billion ≈ $459.33 Million	+34.86%
2010-12-31	CN¥2.33 Billion ≈ $340.61 Million	+11.86%
2009-12-31	CN¥2.08 Billion ≈ $304.49 Million	+67.79%
2008-12-31	CN¥1.24 Billion ≈ $181.47 Million	+6.25%
2007-12-31	CN¥1.17 Billion ≈ $170.79 Million	+5.24%
2006-12-31	CN¥1.11 Billion ≈ $162.28 Million	+44.23%
2005-12-31	CN¥768.89 Million ≈ $112.51 Million	+6.12%
2004-12-31	CN¥724.52 Million ≈ $106.02 Million	+6.31%
2003-12-31	CN¥681.54 Million ≈ $99.73 Million	-0.17%
2002-12-31	CN¥682.71 Million ≈ $99.90 Million	+72.17%
2001-12-31	CN¥396.54 Million ≈ $58.03 Million	+21.98%
2000-12-31	CN¥325.09 Million ≈ $47.57 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Humanwell Healthcare Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 61422.5% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥9.59 Billion	54.41%
Other Components	CN¥8.04 Billion	45.59%
Total Equity	CN¥17.62 Billion	100.00%

Humanwell Healthcare Group Co Ltd Competitors by Market Cap

The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their market capitalization.

Company	Market Cap
NOVA LJUBLJ.BK GDR REG.S F:N1V2	$4.49 Billion
Cochlear Ltd AU:COH	$4.49 Billion
Miniso Group Holding Ltd NYSE:MNSO	$4.49 Billion
Koninklijke Vopak NV AS:VPK	$4.49 Billion
Shenzhen Goodix Technology Co Ltd Class A SHG:603160	$4.49 Billion
Enagás S.A. MC:ENG	$4.48 Billion
Grupo Aeroportuario del Centro Norte SAB de CV NASDAQ:OMAB	$4.48 Billion
TaTaTu SpA PA:ALTTU	$4.48 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Humanwell Healthcare Group Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 17,043,599,963 to 17,623,818,879, a change of 580,218,916 (3.4%).
Net income of 1,329,744,984 contributed positively to equity growth.
Dividend payments of 1,269,309,041 reduced retained earnings.
Other factors increased equity by 519,782,972.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥1.33 Billion	+7.55%
Dividends Paid	CN¥1.27 Billion	-7.2%
Other Changes	CN¥519.78 Million	+2.95%
Total Change	CN¥-	3.40%

Book Value vs Market Value Analysis

This analysis compares Humanwell Healthcare Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.74x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 1.88x to 1.74x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2017-12-31	CN¥9.99	CN¥18.79	x
2018-12-31	CN¥8.01	CN¥18.79	x
2019-12-31	CN¥7.50	CN¥18.79	x
2020-12-31	CN¥6.97	CN¥18.79	x
2021-12-31	CN¥8.05	CN¥18.79	x
2022-12-31	CN¥9.21	CN¥18.79	x
2023-12-31	CN¥10.44	CN¥18.79	x
2024-12-31	CN¥10.80	CN¥18.79	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Humanwell Healthcare Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.55%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 5.23%
• Asset Turnover: 0.70x
• Equity Multiplier: 2.07x
Recent ROE (7.55%) is below the historical average (8.75%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2000	12.66%	19.30%	0.36x	1.80x	CN¥7.65 Million
2001	9.75%	11.95%	0.24x	3.34x	CN¥-740.50K
2002	4.03%	3.45%	0.39x	2.99x	CN¥-28.52 Million
2003	6.02%	5.37%	0.34x	3.31x	CN¥-20.31 Million
2004	7.43%	6.79%	0.32x	3.37x	CN¥-13.89 Million
2005	8.85%	6.88%	0.37x	3.52x	CN¥-6.68 Million
2006	12.15%	14.32%	0.33x	2.60x	CN¥19.05 Million
2007	7.42%	9.79%	0.29x	2.58x	CN¥-24.12 Million
2008	7.77%	7.63%	0.40x	2.54x	CN¥-22.41 Million
2009	11.47%	15.15%	0.40x	1.88x	CN¥25.87 Million
2010	11.09%	9.82%	0.52x	2.17x	CN¥21.23 Million
2011	11.33%	8.29%	0.59x	2.33x	CN¥35.30 Million
2012	13.43%	7.64%	0.68x	2.60x	CN¥103.76 Million
2013	9.62%	6.95%	0.62x	2.24x	CN¥-16.44 Million
2014	9.57%	6.45%	0.58x	2.58x	CN¥-20.51 Million
2015	8.30%	6.50%	0.55x	2.30x	CN¥-134.26 Million
2016	8.29%	6.75%	0.47x	2.63x	CN¥-171.72 Million
2017	15.30%	13.39%	0.44x	2.62x	CN¥716.33 Million
2018	-21.76%	-12.65%	0.53x	3.27x	CN¥-3.44 Billion
2019	8.30%	3.86%	0.62x	3.45x	CN¥-172.64 Million
2020	10.67%	5.64%	0.64x	2.94x	CN¥72.09 Million
2021	10.57%	6.80%	0.59x	2.62x	CN¥74.85 Million
2022	16.52%	11.12%	0.62x	2.40x	CN¥980.41 Million
2023	12.52%	8.70%	0.68x	2.12x	CN¥430.12 Million
2024	7.55%	5.23%	0.70x	2.07x	CN¥-432.64 Million

Industry Comparison

This section compares Humanwell Healthcare Group Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $4,691,234,838
Average return on equity (ROE) among peers: 6.16%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Humanwell Healthcare Group Co Ltd (600079)	CN¥21.41 Billion	12.66%	0.75x	$4.49 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$903.62 Million	4.28%	2.45x	$1.16 Billion
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$1.22 Billion	5.35%	1.27x	$441.99 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$9.87 Billion	20.71%	0.25x	$5.01 Billion
Livzon Pharmaceutical Group Inc (000513)	$1.07 Billion	3.83%	0.46x	$2.80 Billion
Wedge Industrial Co Ltd (000534)	$1.15 Billion	11.42%	1.59x	$3.04 Billion
Yunnan Baiyao Group Co Ltd (000538)	$9.03 Billion	25.71%	0.43x	$13.75 Billion
Hainan Haiyao Co Ltd (000566)	$275.57 Million	17.28%	1.12x	$947.33 Million
Tus Pharmaceutical Group Co Ltd (000590)	$231.22 Million	-38.13%	1.23x	$389.67 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$4.29 Billion	2.31%	2.07x	$1.03 Billion
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$18.87 Billion	8.83%	0.08x	$3.32 Billion

About Humanwell Healthcare Group Co Ltd

SHG:600079 China Drug Manufacturers - Specialty & Generic

Market Cap

$4.49 Billion

CN¥30.67 Billion CNY

Market Cap Rank

#3886 Global

#645 in China

Share Price

CN¥18.79

Change (1 day)

-0.48%

52-Week Range

CN¥17.24 - CN¥23.03

All Time High

CN¥37.30